{
    "SPADE_UN_26159": {
        "Sequence Information": {
            "Peptide Name": "L12 (4-18)",
            "Sequence": "RKAFRWAKRMLKKAA",
            "Sequence Length": 15,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells",
                    "Pubmed ID": "14959890",
                    "Reference": "J Pept Sci. 2004;10:37-46",
                    "Author": "Yang N, Strøm MB, Mekonnen SM, Svendsen JS, Rekdal O",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/14959890"
                }
            ],
            "Mass": 1861.31,
            "PI": 12.0,
            "Net Charge": 7,
            "Hydrophobicity": -0.95,
            "Frequent Amino Acids": "AKR",
            "Absent Amino Acids": "CDEGHINOPQSTUVY",
            "Basic Residues": 7,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 7,
            "Polar Residues": 8,
            "Positive Residues": 7,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_26159",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_15192",
                    "Similarity": 1.0,
                    "Sequence": "RRRKAF"
                },
                {
                    "SPADE_ID": "SPADE_UN_15285",
                    "Similarity": 1.0,
                    "Sequence": "PAWRKAFRWAKRMLKKAA"
                },
                {
                    "SPADE_ID": "SPADE_UN_26157",
                    "Similarity": 1.0,
                    "Sequence": "AWRKAFRWAKRMLKKAA"
                }
            ],
            "Hemolytic Activity": "Human fibroblasts MRC-5:IC50=135 µM",
            "Target Organism": "Murine fibrosarcoma MethA(IC50=33.4µM),Human mammary carcinoma MT-1(IC50=27µM),Human lung carcinoma A549(IC50=31µM),Escherichia coli ATCC 25922(MIC=5.1µM),Staphylococcus aureus ATCC 25923(MIC=3.9µM)"
        }
    }
}